Sales from operations up by 17% for the quarter ended March 31, 2019
Mumbai: Procter & Gamble Health Limited (formerly Merck Limited) announced today its financial results for the quarter ended March 31, 2018. The company has recorded total revenue of ₹249 crores, up 22.2% vs. a year ago (Sales from operations up by 17%) driven by a strong performance across brands, growth in exports, higher interest income and improved execution.
The Profit After Tax (PAT) was ₹40.7 crores Vs ₹22.7 crores from continued operations, up versus a year ago driven by high-interest income and operational efficiencies.
Milind Thatte, Managing Director, Procter & Gamble Health Limited said, “We have continued our solid growth trajectory, recording a robust 17% growth in this quarter. With a brand portfolio backed by science and trusted by doctors, pharmacists and consumers, and the best of Consumer Health capabilities and cultures, we are working towards creating a much stronger presence in India’s fast-growing Consumer Health industry.”
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Sign me up for the newsletter!
Notify me of follow-up comments by email.
Notify me of new posts by email.
Hero ISL playoff race goes down to the wire; top-four battle explained
South Africa (SA) Rugby congratulates Springboks on prestigious Laureus Award
ABP Asmita conducts ‘Asmita Sanman Puraskar 2020’ in Gujarat
Continuing the love, IndiGo announces its international sale starting at INR 3499
Tech in 2020 That’s Changing The Way Humans Behave!
2014 The Global Indian New Network (TGINN)